Comparative Study of Clarithromycin- versus Metronidazole-Based Triple Therapy as First-Line Eradication for Helicobacter pylori

Comparative Study of Clarithromycin- versus Metronidazole-Based Triple Therapy as First-Line Eradication for Helicobacter pylori

Teppei Adachi;Shigenaga Matsui;Tomohiro Watanabe;Kazuki Okamoto;Ayana Okamoto;Masashi Kono;Mitsunari Yamada;Tomoyuki Nagai;Yoriaki Komeda;Kosuke Minaga;Ken Kamata;Kentaro Yamao;Mamoru Takenaka;Yutaka Asakuma;Toshiharu Sakurai;Naoshi Nishida;Hiroshi Kashida;Masatoshi Kudo;
oncology 2017 Vol. 93 pp. 15-19
216
adachi2017oncologycomparative

Abstract

Introduction: Clarithromycin (CAM)-based triple therapy comprising proton pump inhibitors and amoxicillin is administered as first-line eradication treatment against Helicobacter pylori infection. However, the eradication rate achieved with CAM-based triple therapy has decreased to H. pylori eradication. Methods:H. pylori-positive patients were tre

Citation

ID: 118653
Ref Key: adachi2017oncologycomparative
Use this key to autocite in SciMatic or Thesis Manager

References

Blockchain Verification

Account:
NFT Contract Address:
0x95644003c57E6F55A65596E3D9Eac6813e3566dA
Article ID:
118653
Unique Identifier:
Network:
Scimatic Chain (ID: 481)
Loading...
Blockchain Readiness Checklist
Authors
Abstract
Journal Name
Year
Title
5/5
Creates 1,000,000 NFT tokens for this article
Token Features:
  • ERC-1155 Standard NFT
  • 1 Million Supply per Article
  • Transferable via MetaMask
  • Permanent Blockchain Record
Blockchain QR Code
Scan with Saymatik Web3.0 Wallet

Saymatik Web3.0 Wallet